Sustainability & Climate

Jennifer Reale's promotion to CFO at Office Practicum signals a strategic push to integrate its platform and navigate a consolidating healthcare tech market.

Blue Heron is building homes based on your physiology. Is this the future of wellness or the ultimate luxury status symbol in a trillion-dollar market?

IEC Holden, a century-old industrial leader, is now Rockit Motors, signaling an aggressive push to dominate North America's booming electrification market.

A renewed partnership will make vital cardiovascular and neurological research more accessible, signaling a major shift in medical publishing.

Health-Ade's new campaign with Lindsay Lohan is more than celebrity sparkle; it's a calculated play for the booming wellness market. Here's the inside story.

A new oral drug is being tested with existing therapies, offering a two-pronged attack on the glycogen buildup that defines this debilitating rare disease.

The National Bleeding Disorders Foundation taps celebrity power for a live event, aiming to spotlight underdiagnosed conditions and transform advocacy.

Coway updates its iconic Airmega Mighty. With new smarts and a sleek design, can the Mighty2 fend off fierce rivals in a market hungry for clean air?

A new study reveals a massive shift in retirement strategy, as economic pressures and a desire for purpose lead Americans to embrace a more fluid future.

The man who scaled ASOS to a global giant now joins Kornit Digital to help dismantle the old supply chain and build a sustainable, on-demand future.

Amid a growing need for connection, a national call for hospice volunteers highlights the profound benefits for both patients and the givers themselves.

Biotech firm Humacyte raises $20M to accelerate sales of its FDA-approved Symvess® and fund crucial trials for new hemodialysis applications.

A novel drug designed to eliminate stubborn cancer proteins enters human trials, offering a new strategy for ALK+ lung cancer patients facing resistance.

With pivotal trials advancing, key FDA alignment, and a strong cash position, Taysha Gene Therapies charts a clear path toward a potential breakthrough.

Following its 2024 acquisition, Hillcore Industrial promotes CEDA’s CEO and CFO to lead its entire portfolio, signaling a major strategic integration.

ImmunoBrain's novel immunotherapy for Alzheimer's avoids key safety issues of other drugs and shows positive biomarker data in a Phase 1b trial.

Amidst record sales but widening losses, the Vietnamese automaker is overhauling its strategy, betting on smart factories and AI to carve out a profitable future.

A new app feature aims to combat costly workplace loneliness, but can a digital platform truly solve a deeply human problem of disconnection?

Endevica Bio launches Kalohexis, a new biotech aiming to disrupt the obesity market with a drug that resets the body's 'metabolic thermostat'.

The toy giant's 600,000-square-foot facility is more than a warehouse; it's a key move in its plan for faster delivery and supply chain dominance.